Rank | Gene Set | Z-score |
---|---|---|
1 | microglial cell activation (GO:0001774) | 5.92161048 |
2 | cellular response to thyroid hormone stimulus (GO:0097067) | 5.41012805 |
3 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.38012751 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.36611868 |
5 | modulation by symbiont of host defense response (GO:0052031) | 5.36611868 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.36611868 |
7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.36611868 |
8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.36611868 |
9 | modulation by symbiont of host immune response (GO:0052553) | 5.36611868 |
10 | macrophage activation involved in immune response (GO:0002281) | 4.85237209 |
11 | glomerular visceral epithelial cell development (GO:0072015) | 4.62754039 |
12 | glycolipid catabolic process (GO:0019377) | 4.59068926 |
13 | plasma lipoprotein particle clearance (GO:0034381) | 4.57745359 |
14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.34709403 |
15 | response to thyroid hormone (GO:0097066) | 4.33906072 |
16 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.33771011 |
17 | N-acetylneuraminate metabolic process (GO:0006054) | 4.28753485 |
18 | detection of molecule of bacterial origin (GO:0032490) | 4.22592251 |
19 | glomerular epithelial cell development (GO:0072310) | 4.13379700 |
20 | positive regulation of interferon-alpha production (GO:0032727) | 4.07414091 |
21 | amino sugar catabolic process (GO:0046348) | 4.06386643 |
22 | regulation of apoptotic cell clearance (GO:2000425) | 4.02190904 |
23 | barbed-end actin filament capping (GO:0051016) | 4.01656772 |
24 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.99129895 |
25 | ceramide catabolic process (GO:0046514) | 3.94084286 |
26 | pinocytosis (GO:0006907) | 3.92364674 |
27 | positive regulation of leukocyte degranulation (GO:0043302) | 3.92291837 |
28 | complement activation, alternative pathway (GO:0006957) | 3.89516592 |
29 | regulation of interferon-alpha production (GO:0032647) | 3.81203229 |
30 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.80163994 |
31 | protein-lipid complex remodeling (GO:0034368) | 3.79632484 |
32 | macromolecular complex remodeling (GO:0034367) | 3.79632484 |
33 | plasma lipoprotein particle remodeling (GO:0034369) | 3.79632484 |
34 | positive regulation of chemokine secretion (GO:0090197) | 3.79406187 |
35 | low-density lipoprotein particle clearance (GO:0034383) | 3.78579631 |
36 | cellular response to cadmium ion (GO:0071276) | 3.75968638 |
37 | negative regulation of interleukin-12 production (GO:0032695) | 3.75814693 |
38 | macrophage activation (GO:0042116) | 3.75804401 |
39 | plasma lipoprotein particle organization (GO:0071827) | 3.63517186 |
40 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.58493725 |
41 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.51098765 |
42 | positive regulation of mast cell degranulation (GO:0043306) | 3.51098765 |
43 | negative regulation of sterol transport (GO:0032372) | 3.50443797 |
44 | negative regulation of cholesterol transport (GO:0032375) | 3.50443797 |
45 | high-density lipoprotein particle remodeling (GO:0034375) | 3.41723266 |
46 | regulation of superoxide anion generation (GO:0032928) | 3.38881427 |
47 | regulation of leukocyte degranulation (GO:0043300) | 3.38583721 |
48 | adenosine receptor signaling pathway (GO:0001973) | 3.37911743 |
49 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.37872513 |
50 | regulation of mast cell degranulation (GO:0043304) | 3.37070682 |
51 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.33110640 |
52 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.31206838 |
53 | response to host immune response (GO:0052572) | 3.31206838 |
54 | I-kappaB phosphorylation (GO:0007252) | 3.26434984 |
55 | macrophage differentiation (GO:0030225) | 3.25938038 |
56 | glomerular basement membrane development (GO:0032836) | 3.25579222 |
57 | membrane lipid catabolic process (GO:0046466) | 3.21094607 |
58 | positive regulation of extracellular matrix organization (GO:1903055) | 3.19567259 |
59 | * positive regulation of phagocytosis (GO:0050766) | 3.16368757 |
60 | positive regulation of mast cell activation (GO:0033005) | 3.13588048 |
61 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.11289436 |
62 | response to host (GO:0075136) | 3.11289436 |
63 | response to host defenses (GO:0052200) | 3.11289436 |
64 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.11120628 |
65 | negative regulation of granulocyte differentiation (GO:0030853) | 3.10369005 |
66 | negative regulation of fibrinolysis (GO:0051918) | 3.08075809 |
67 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.07951826 |
68 | response to cholesterol (GO:0070723) | 3.05702785 |
69 | * apoptotic cell clearance (GO:0043277) | 3.03426016 |
70 | sphingolipid catabolic process (GO:0030149) | 3.03058952 |
71 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.02664804 |
72 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.02664804 |
73 | mannose metabolic process (GO:0006013) | 3.02606022 |
74 | peptide catabolic process (GO:0043171) | 3.01896108 |
75 | cellular response to ethanol (GO:0071361) | 3.01158390 |
76 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.98568099 |
77 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.98398487 |
78 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.97668567 |
79 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.95347674 |
80 | regulation of macrophage chemotaxis (GO:0010758) | 2.94290890 |
81 | lysosome organization (GO:0007040) | 2.93855369 |
82 | lytic vacuole organization (GO:0080171) | 2.93855369 |
83 | phagocytosis, engulfment (GO:0006911) | 2.92305031 |
84 | regulation of protein activation cascade (GO:2000257) | 2.91905767 |
85 | sterol transport (GO:0015918) | 2.91834105 |
86 | cholesterol transport (GO:0030301) | 2.91834105 |
87 | cell-cell junction maintenance (GO:0045217) | 2.91497659 |
88 | detection of external biotic stimulus (GO:0098581) | 2.90123593 |
89 | regulation of complement activation (GO:0030449) | 2.89904506 |
90 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.89668873 |
91 | lipoprotein metabolic process (GO:0042157) | 2.88161976 |
92 | protein localization to endosome (GO:0036010) | 2.87794679 |
93 | chondroitin sulfate catabolic process (GO:0030207) | 2.86748668 |
94 | phospholipid efflux (GO:0033700) | 2.83697505 |
95 | regulation of beta-amyloid formation (GO:1902003) | 2.82500302 |
96 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.80539168 |
97 | alanine transport (GO:0032328) | 2.79673954 |
98 | positive regulation of steroid metabolic process (GO:0045940) | 2.79343672 |
99 | monocyte chemotaxis (GO:0002548) | 2.75906356 |
100 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.75682239 |
101 | eosinophil chemotaxis (GO:0048245) | 2.73909445 |
102 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.72965512 |
103 | reverse cholesterol transport (GO:0043691) | 2.72938320 |
104 | regulation of chemokine secretion (GO:0090196) | 2.71776793 |
105 | regulation of hypersensitivity (GO:0002883) | 2.69887352 |
106 | negative regulation of tissue remodeling (GO:0034104) | 2.69386140 |
107 | oligosaccharide catabolic process (GO:0009313) | 2.68487900 |
108 | positive regulation of macrophage cytokine production (GO:0060907) | 2.65915535 |
109 | T-helper 1 type immune response (GO:0042088) | 2.65253148 |
110 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.64010586 |
111 | osteoclast differentiation (GO:0030316) | 2.63511909 |
112 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.62364247 |
113 | sodium-independent organic anion transport (GO:0043252) | 2.62095594 |
114 | response to sterol (GO:0036314) | 2.61046506 |
115 | positive regulation of p38MAPK cascade (GO:1900745) | 2.57817075 |
116 | phospholipid homeostasis (GO:0055091) | 2.55961082 |
117 | positive regulation of cholesterol efflux (GO:0010875) | 2.54858586 |
118 | positive regulation of interferon-beta production (GO:0032728) | 2.54748172 |
119 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.54344706 |
120 | low-density lipoprotein particle remodeling (GO:0034374) | 2.53908174 |
121 | myeloid cell activation involved in immune response (GO:0002275) | 2.52202928 |
122 | negative regulation of bone resorption (GO:0045779) | 2.51066962 |
123 | response to muramyl dipeptide (GO:0032495) | 2.48918634 |
124 | response to peptidoglycan (GO:0032494) | 2.47353540 |
125 | keratan sulfate catabolic process (GO:0042340) | 2.47335660 |
126 | L-amino acid import (GO:0043092) | 2.45384850 |
127 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.45218206 |
128 | angiotensin maturation (GO:0002003) | 2.44385460 |
129 | protein-lipid complex assembly (GO:0065005) | 2.44278096 |
130 | monocyte differentiation (GO:0030224) | 2.42901646 |
131 | protein carboxylation (GO:0018214) | 2.42859510 |
132 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.42859510 |
133 | plasma lipoprotein particle assembly (GO:0034377) | 2.42016098 |
134 | regulation of cholesterol storage (GO:0010885) | 2.41211048 |
135 | purinergic receptor signaling pathway (GO:0035587) | 2.41160314 |
136 | neutrophil activation involved in immune response (GO:0002283) | 2.40413646 |
137 | cellular extravasation (GO:0045123) | 2.39050105 |
138 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.37382274 |
139 | endothelium development (GO:0003158) | 2.37190989 |
140 | eosinophil migration (GO:0072677) | 2.33015375 |
141 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.32572102 |
142 | glycosphingolipid catabolic process (GO:0046479) | 2.31210980 |
143 | regulation of cholesterol esterification (GO:0010872) | 2.30727469 |
144 | ruffle organization (GO:0031529) | 2.30310348 |
145 | positive regulation of sterol transport (GO:0032373) | 2.29585878 |
146 | positive regulation of cholesterol transport (GO:0032376) | 2.29585878 |
147 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.29109600 |
148 | macrophage chemotaxis (GO:0048246) | 2.28662661 |
149 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.28451543 |
150 | regulation of alkaline phosphatase activity (GO:0010692) | 2.28250906 |
151 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.27427426 |
152 | cholesterol efflux (GO:0033344) | 2.27332245 |
153 | regulation of mononuclear cell migration (GO:0071675) | 2.26346939 |
154 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.26203905 |
155 | negative regulation of lipid storage (GO:0010888) | 2.25014420 |
156 | cellular response to exogenous dsRNA (GO:0071360) | 2.24269894 |
157 | hyaluronan catabolic process (GO:0030214) | 2.22630748 |
158 | cell adhesion mediated by integrin (GO:0033627) | 2.21281568 |
159 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.20609796 |
160 | alpha-linolenic acid metabolic process (GO:0036109) | 2.20593959 |
161 | protein-lipid complex subunit organization (GO:0071825) | 2.19363645 |
162 | positive regulation of antigen processing and presentation (GO:0002579) | 2.18129594 |
163 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.17547677 |
164 | amino acid import (GO:0043090) | 2.17158917 |
165 | glomerulus development (GO:0032835) | 2.16904666 |
166 | regulation of monocyte chemotaxis (GO:0090025) | 2.16722453 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.60228710 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.30546069 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.03954687 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.02354196 |
5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62078376 |
6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.60575956 |
7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.57380720 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.23475584 |
9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.20660006 |
10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11813850 |
11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.07764036 |
12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04356210 |
13 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.02361192 |
14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.00648262 |
15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.83848902 |
16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.78803777 |
17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.78117859 |
18 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75743209 |
19 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.74988106 |
20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70581160 |
21 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65375710 |
22 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.57818968 |
23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.57773516 |
24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57415714 |
25 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56565923 |
26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56313224 |
27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.55391720 |
28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55166907 |
29 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.52958202 |
30 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.51810374 |
31 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.51518243 |
32 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48575558 |
33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46328618 |
34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.45851084 |
35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.43061466 |
36 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41643811 |
37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39955074 |
38 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39244580 |
39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.38352620 |
40 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35109938 |
41 | TP53_16413492_ChIP-PET_HCT116_Human | 1.33359360 |
42 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32972028 |
43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32502627 |
44 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.29089526 |
45 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.28543764 |
46 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.27248302 |
47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26716198 |
48 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.24945180 |
49 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24084074 |
50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.23160802 |
51 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.22888003 |
52 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.20804710 |
53 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.19548671 |
54 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18320762 |
55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17801740 |
56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.17511825 |
57 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.17385920 |
58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17035666 |
59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.17027123 |
60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16454423 |
61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16426697 |
62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16349589 |
63 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15280065 |
64 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15280065 |
65 | KDM2B_26808549_Chip-Seq_K562_Human | 1.14862901 |
66 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.14159227 |
67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13761512 |
68 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13179343 |
69 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12981767 |
70 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12806033 |
71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12626066 |
72 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12079522 |
73 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11576823 |
74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10963319 |
75 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10570651 |
76 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09835911 |
77 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08808670 |
78 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08420925 |
79 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07807446 |
80 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.06156020 |
81 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05085844 |
82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04518155 |
83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04196534 |
84 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.04122763 |
85 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03424678 |
86 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.02215136 |
87 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01867558 |
88 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01867558 |
89 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01378598 |
90 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01311530 |
91 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01269072 |
92 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.00826811 |
93 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.00298986 |
94 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00208462 |
95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99019483 |
96 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.98398039 |
97 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.97940469 |
98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97508850 |
99 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96777358 |
100 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.96733211 |
101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96354551 |
102 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94972509 |
103 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93990660 |
104 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93265704 |
105 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93265021 |
106 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93026651 |
107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92997485 |
108 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.92264314 |
109 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90871166 |
110 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90034689 |
111 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.89404964 |
112 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89303346 |
113 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89155206 |
114 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.88947445 |
115 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.88834013 |
116 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.88303210 |
117 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87951901 |
118 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87862125 |
119 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.87142793 |
120 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86986573 |
121 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85587062 |
122 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.85550866 |
123 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84454206 |
124 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.84197680 |
125 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83683760 |
126 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83007483 |
127 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82959532 |
128 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.82166740 |
129 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.82043301 |
130 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82038664 |
131 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81405959 |
132 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81304377 |
133 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79592982 |
134 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.79127748 |
135 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.78854334 |
136 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.77759096 |
137 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.77736601 |
138 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.77640477 |
139 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.77010865 |
140 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.75685739 |
141 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.74803876 |
142 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.72756856 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003191_abnormal_cellular_cholesterol | 4.43748918 |
2 | MP0005058_abnormal_lysosome_morphology | 4.24483298 |
3 | MP0009840_abnormal_foam_cell | 3.79984415 |
4 | MP0006082_CNS_inflammation | 3.38904189 |
5 | MP0003690_abnormal_glial_cell | 3.08471343 |
6 | MP0002254_reproductive_system_inflammat | 2.87480218 |
7 | MP0005360_urolithiasis | 2.80341805 |
8 | MP0003329_amyloid_beta_deposits | 2.67087722 |
9 | MP0003172_abnormal_lysosome_physiology | 2.63092824 |
10 | MP0005167_abnormal_blood-brain_barrier | 2.62461587 |
11 | MP0003303_peritoneal_inflammation | 2.60426365 |
12 | MP0003075_altered_response_to | 2.41585432 |
13 | MP0001835_abnormal_antigen_presentation | 2.37495808 |
14 | MP0002419_abnormal_innate_immunity | 2.35697212 |
15 | MP0003252_abnormal_bile_duct | 2.28725660 |
16 | MP0003300_gastrointestinal_ulcer | 2.18829476 |
17 | MP0002139_abnormal_hepatobiliary_system | 2.04474562 |
18 | MP0003724_increased_susceptibility_to | 2.03390576 |
19 | * MP0005464_abnormal_platelet_physiology | 1.88358272 |
20 | MP0005085_abnormal_gallbladder_physiolo | 1.85645694 |
21 | MP0005670_abnormal_white_adipose | 1.85463064 |
22 | MP0003436_decreased_susceptibility_to | 1.82645627 |
23 | MP0003183_abnormal_peptide_metabolism | 1.81534148 |
24 | MP0002148_abnormal_hypersensitivity_rea | 1.79384584 |
25 | MP0000685_abnormal_immune_system | 1.68129368 |
26 | MP0005166_decreased_susceptibility_to | 1.68123902 |
27 | MP0003195_calcinosis | 1.66392112 |
28 | MP0000343_altered_response_to | 1.64542858 |
29 | MP0005365_abnormal_bile_salt | 1.64352574 |
30 | MP0001533_abnormal_skeleton_physiology | 1.62746834 |
31 | MP0002998_abnormal_bone_remodeling | 1.62289160 |
32 | MP0005451_abnormal_body_composition | 1.60564936 |
33 | MP0008260_abnormal_autophagy | 1.57648376 |
34 | MP0010329_abnormal_lipoprotein_level | 1.56910320 |
35 | MP0000604_amyloidosis | 1.55263531 |
36 | MP0002452_abnormal_antigen_presenting | 1.54271141 |
37 | MP0000569_abnormal_digit_pigmentation | 1.53270800 |
38 | MP0009384_cardiac_valve_regurgitation | 1.50610643 |
39 | MP0003279_aneurysm | 1.48661477 |
40 | MP0004019_abnormal_vitamin_homeostasis | 1.45445623 |
41 | * MP0008469_abnormal_protein_level | 1.42507076 |
42 | MP0005332_abnormal_amino_acid | 1.42145472 |
43 | MP0001853_heart_inflammation | 1.41993062 |
44 | MP0003632_abnormal_nervous_system | 1.41252756 |
45 | MP0003045_fibrosis | 1.41147248 |
46 | MP0008875_abnormal_xenobiotic_pharmacok | 1.39406586 |
47 | * MP0005000_abnormal_immune_tolerance | 1.39092456 |
48 | MP0005025_abnormal_response_to | 1.38404450 |
49 | MP0005397_hematopoietic_system_phenotyp | 1.36107898 |
50 | MP0001545_abnormal_hematopoietic_system | 1.36107898 |
51 | MP0001790_abnormal_immune_system | 1.32131459 |
52 | MP0005387_immune_system_phenotype | 1.32131459 |
53 | MP0009764_decreased_sensitivity_to | 1.32106251 |
54 | * MP0002723_abnormal_immune_serum | 1.31449634 |
55 | MP0006054_spinal_hemorrhage | 1.27458758 |
56 | MP0002136_abnormal_kidney_physiology | 1.25902553 |
57 | MP0000767_abnormal_smooth_muscle | 1.19250995 |
58 | MP0001800_abnormal_humoral_immune | 1.17435004 |
59 | MP0004510_myositis | 1.15625615 |
60 | * MP0001845_abnormal_inflammatory_respons | 1.13870265 |
61 | MP0004883_abnormal_blood_vessel | 1.13782763 |
62 | * MP0005671_abnormal_response_to | 1.11481386 |
63 | MP0001851_eye_inflammation | 1.10867194 |
64 | MP0010368_abnormal_lymphatic_system | 1.10245328 |
65 | MP0005666_abnormal_adipose_tissue | 1.09929297 |
66 | MP0004130_abnormal_muscle_cell | 1.09355972 |
67 | MP0005164_abnormal_response_to | 1.08762016 |
68 | MP0000609_abnormal_liver_physiology | 1.08665392 |
69 | * MP0001819_abnormal_immune_cell | 1.08356926 |
70 | MP0000858_altered_metastatic_potential | 1.07426840 |
71 | MP0008004_abnormal_stomach_pH | 1.07260623 |
72 | MP0002118_abnormal_lipid_homeostasis | 1.06299393 |
73 | MP0004947_skin_inflammation | 1.05782536 |
74 | MP0009643_abnormal_urine_homeostasis | 1.05704466 |
75 | MP0003011_delayed_dark_adaptation | 1.03906885 |
76 | * MP0002420_abnormal_adaptive_immunity | 1.03597788 |
77 | MP0001666_abnormal_nutrient_absorption | 1.03401306 |
78 | MP0005310_abnormal_salivary_gland | 1.03318861 |
79 | MP0000249_abnormal_blood_vessel | 1.03048272 |
80 | MP0003566_abnormal_cell_adhesion | 1.02831976 |
81 | MP0003878_abnormal_ear_physiology | 1.01930168 |
82 | MP0005377_hearing/vestibular/ear_phenot | 1.01930168 |
83 | MP0009785_altered_susceptibility_to | 1.01508207 |
84 | MP0003453_abnormal_keratinocyte_physiol | 1.01415496 |
85 | MP0002405_respiratory_system_inflammati | 1.01257691 |
86 | MP0009278_abnormal_bone_marrow | 1.00788059 |
87 | MP0002896_abnormal_bone_mineralization | 0.98059729 |
88 | MP0001915_intracranial_hemorrhage | 0.97818808 |
89 | MP0002877_abnormal_melanocyte_morpholog | 0.96865343 |
90 | MP0001879_abnormal_lymphatic_vessel | 0.96591176 |
91 | MP0005595_abnormal_vascular_smooth | 0.95362188 |
92 | MP0003633_abnormal_nervous_system | 0.94326364 |
93 | MP0003705_abnormal_hypodermis_morpholog | 0.93131278 |
94 | MP0002135_abnormal_kidney_morphology | 0.92726548 |
95 | MP0004185_abnormal_adipocyte_glucose | 0.92261412 |
96 | MP0003091_abnormal_cell_migration | 0.89875124 |
97 | MP0005165_increased_susceptibility_to | 0.89633094 |
98 | MP0003631_nervous_system_phenotype | 0.88451245 |
99 | MP0005076_abnormal_cell_differentiation | 0.86617279 |
100 | MP0003828_pulmonary_edema | 0.86389922 |
101 | MP0005257_abnormal_intraocular_pressure | 0.86063293 |
102 | MP0003656_abnormal_erythrocyte_physiolo | 0.85127260 |
103 | MP0004272_abnormal_basement_membrane | 0.85011249 |
104 | MP0003448_altered_tumor_morphology | 0.84768855 |
105 | MP0000465_gastrointestinal_hemorrhage | 0.83674550 |
106 | MP0002928_abnormal_bile_duct | 0.82856904 |
107 | MP0001756_abnormal_urination | 0.80766616 |
108 | MP0003879_abnormal_hair_cell | 0.80643319 |
109 | MP0005023_abnormal_wound_healing | 0.80501058 |
110 | MP0002971_abnormal_brown_adipose | 0.79875222 |
111 | MP0005647_abnormal_sex_gland | 0.78945678 |
112 | MP0002933_joint_inflammation | 0.78339171 |
113 | MP0003795_abnormal_bone_structure | 0.77582266 |
114 | MP0000371_diluted_coat_color | 0.77460074 |
115 | MP0002138_abnormal_hepatobiliary_system | 0.77435294 |
116 | MP0005390_skeleton_phenotype | 0.77253532 |
117 | * MP0009763_increased_sensitivity_to | 0.77045842 |
118 | MP0005197_abnormal_uvea_morphology | 0.76305777 |
119 | MP0000920_abnormal_myelination | 0.75409087 |
120 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75191235 |
121 | MP0009115_abnormal_fat_cell | 0.73805980 |
122 | MP0002166_altered_tumor_susceptibility | 0.73501056 |
123 | MP0000230_abnormal_systemic_arterial | 0.72920549 |
124 | MP0002168_other_aberrant_phenotype | 0.72710343 |
125 | MP0003634_abnormal_glial_cell | 0.71370329 |
126 | MP0001849_ear_inflammation | 0.66960213 |
127 | * MP0002090_abnormal_vision | 0.65982069 |
128 | MP0003806_abnormal_nucleotide_metabolis | 0.61829817 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus (HP:0002725) | 7.37910620 |
2 | Glomerulonephritis (HP:0000099) | 6.96677033 |
3 | Complement deficiency (HP:0004431) | 4.90221925 |
4 | Nephritis (HP:0000123) | 4.80000255 |
5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.30331187 |
6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.30331187 |
7 | Abnormality of glycolipid metabolism (HP:0010969) | 4.30331187 |
8 | Increased cerebral lipofuscin (HP:0011813) | 4.24095361 |
9 | Dysostosis multiplex (HP:0000943) | 3.97655700 |
10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.96317600 |
11 | Recurrent abscess formation (HP:0002722) | 3.75418094 |
12 | Recurrent bacterial skin infections (HP:0005406) | 3.74133194 |
13 | Cerebral inclusion bodies (HP:0100314) | 3.70396158 |
14 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.69237937 |
15 | Arterial tortuosity (HP:0005116) | 3.64052004 |
16 | Abnormality of complement system (HP:0005339) | 3.59563138 |
17 | Vacuolated lymphocytes (HP:0001922) | 3.51774049 |
18 | Eczematoid dermatitis (HP:0000976) | 3.50615175 |
19 | Hematochezia (HP:0002573) | 3.49111442 |
20 | Axonal loss (HP:0003447) | 3.44404293 |
21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.42550573 |
22 | Cerebral aneurysm (HP:0004944) | 3.31910859 |
23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.20875378 |
24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.20875378 |
25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.20875378 |
26 | Mucopolysacchariduria (HP:0008155) | 3.18838075 |
27 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.18838075 |
28 | Mesangial abnormality (HP:0001966) | 3.18173373 |
29 | Vascular tortuosity (HP:0004948) | 3.16838919 |
30 | Autoimmune thrombocytopenia (HP:0001973) | 3.14438212 |
31 | Focal segmental glomerulosclerosis (HP:0000097) | 3.02665455 |
32 | Myocardial infarction (HP:0001658) | 3.02083427 |
33 | Urethral obstruction (HP:0000796) | 2.99932579 |
34 | Purpura (HP:0000979) | 2.92249854 |
35 | Joint hemorrhage (HP:0005261) | 2.80818710 |
36 | Aortic aneurysm (HP:0004942) | 2.75912013 |
37 | Agnosia (HP:0010524) | 2.71821851 |
38 | Amyloidosis (HP:0011034) | 2.65007299 |
39 | Hypoalphalipoproteinemia (HP:0003233) | 2.63452095 |
40 | Hydroxyprolinuria (HP:0003080) | 2.62380548 |
41 | Abnormality of proline metabolism (HP:0010907) | 2.62380548 |
42 | Mutism (HP:0002300) | 2.61239098 |
43 | Abnormality of the periventricular white matter (HP:0002518) | 2.59710384 |
44 | Apathy (HP:0000741) | 2.58359999 |
45 | Abnormality of macrophages (HP:0004311) | 2.57008274 |
46 | Disinhibition (HP:0000734) | 2.54782638 |
47 | Diminished motivation (HP:0000745) | 2.47515444 |
48 | Nuclear cataract (HP:0100018) | 2.47443844 |
49 | Metaphyseal irregularity (HP:0003025) | 2.47038212 |
50 | Personality changes (HP:0000751) | 2.46971619 |
51 | Colitis (HP:0002583) | 2.44155257 |
52 | Tetraparesis (HP:0002273) | 2.43863219 |
53 | Xanthomatosis (HP:0000991) | 2.42923459 |
54 | Conjunctival telangiectasia (HP:0000524) | 2.36595676 |
55 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.35768698 |
56 | Recurrent skin infections (HP:0001581) | 2.34107507 |
57 | Chronic diarrhea (HP:0002028) | 2.33445104 |
58 | Global brain atrophy (HP:0002283) | 2.32106514 |
59 | Pathologic fracture (HP:0002756) | 2.31898687 |
60 | Upper motor neuron abnormality (HP:0002127) | 2.29757490 |
61 | Inappropriate behavior (HP:0000719) | 2.29421899 |
62 | Disproportionate tall stature (HP:0001519) | 2.28423069 |
63 | Basal ganglia calcification (HP:0002135) | 2.26684204 |
64 | Peripheral demyelination (HP:0011096) | 2.23993398 |
65 | Neurofibrillary tangles (HP:0002185) | 2.21188398 |
66 | Spontaneous hematomas (HP:0007420) | 2.18597796 |
67 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.15658580 |
68 | Skin nodule (HP:0200036) | 2.14746485 |
69 | Deep venous thrombosis (HP:0002625) | 2.13950784 |
70 | Glomerulosclerosis (HP:0000096) | 2.13234002 |
71 | Hyperlipoproteinemia (HP:0010980) | 2.12290462 |
72 | Gingivitis (HP:0000230) | 2.08661309 |
73 | Sensorimotor neuropathy (HP:0007141) | 2.06481485 |
74 | Vertebral compression fractures (HP:0002953) | 2.04945915 |
75 | Esophageal varix (HP:0002040) | 2.03017137 |
76 | Beaking of vertebral bodies (HP:0004568) | 2.02599776 |
77 | Thick nail (HP:0001805) | 2.02043506 |
78 | Neuronal loss in central nervous system (HP:0002529) | 2.01699833 |
79 | Clumsiness (HP:0002312) | 2.01671434 |
80 | Bone pain (HP:0002653) | 1.97914829 |
81 | Increased serum ferritin (HP:0003281) | 1.96397237 |
82 | Mediastinal lymphadenopathy (HP:0100721) | 1.96120376 |
83 | Abnormality of the common coagulation pathway (HP:0010990) | 1.93994518 |
84 | Supranuclear gaze palsy (HP:0000605) | 1.92965785 |
85 | Aortic dissection (HP:0002647) | 1.92783627 |
86 | Abnormal albumin level (HP:0012116) | 1.92455004 |
87 | Hypoalbuminemia (HP:0003073) | 1.92455004 |
88 | Hemorrhage of the eye (HP:0011885) | 1.92186112 |
89 | Periodontitis (HP:0000704) | 1.91216527 |
90 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90605634 |
91 | Hepatosplenomegaly (HP:0001433) | 1.89893424 |
92 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.86863356 |
93 | Aplasia of the phalanges of the hand (HP:0009802) | 1.86863356 |
94 | Aplasia involving bones of the extremities (HP:0009825) | 1.86863356 |
95 | Increased CSF protein (HP:0002922) | 1.83682316 |
96 | Loss of speech (HP:0002371) | 1.83556262 |
97 | Polygenic inheritance (HP:0010982) | 1.82843940 |
98 | Polycythemia (HP:0001901) | 1.82092810 |
99 | Striae distensae (HP:0001065) | 1.80632500 |
100 | Gingival bleeding (HP:0000225) | 1.80006299 |
101 | Abnormality of the lumbar spine (HP:0100712) | 1.79421048 |
102 | Mitral stenosis (HP:0001718) | 1.79419792 |
103 | Thoracic kyphosis (HP:0002942) | 1.78951763 |
104 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.78634981 |
105 | Recurrent fungal infections (HP:0002841) | 1.78422003 |
106 | Hypolipoproteinemia (HP:0010981) | 1.76708010 |
107 | Asymmetric septal hypertrophy (HP:0001670) | 1.76271133 |
108 | Mitral valve prolapse (HP:0001634) | 1.76175582 |
109 | Progressive neurologic deterioration (HP:0002344) | 1.76132186 |
110 | Prolonged neonatal jaundice (HP:0006579) | 1.75279194 |
111 | Dementia (HP:0000726) | 1.75153569 |
112 | Inflammation of the large intestine (HP:0002037) | 1.71777503 |
113 | Flat acetabular roof (HP:0003180) | 1.71729125 |
114 | Cardiomegaly (HP:0001640) | 1.69459019 |
115 | Vascular calcification (HP:0004934) | 1.69307867 |
116 | Hypercholesterolemia (HP:0003124) | 1.68388724 |
117 | * Progressive visual loss (HP:0000529) | 1.68043166 |
118 | Ovoid vertebral bodies (HP:0003300) | 1.66723676 |
119 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.65719497 |
120 | Prolonged partial thromboplastin time (HP:0003645) | 1.65597439 |
121 | Multiple enchondromatosis (HP:0005701) | 1.65022016 |
122 | Spondylolisthesis (HP:0003302) | 1.64661429 |
123 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.64658248 |
124 | Osteolytic defects of the hand bones (HP:0009699) | 1.64658248 |
125 | Abnormality of the thoracic spine (HP:0100711) | 1.63595890 |
126 | Arnold-Chiari malformation (HP:0002308) | 1.62889264 |
127 | Hemiplegia (HP:0002301) | 1.61781670 |
128 | Epidermoid cyst (HP:0200040) | 1.61578758 |
129 | Abnormality of iron homeostasis (HP:0011031) | 1.59349828 |
130 | Polyneuropathy (HP:0001271) | 1.57960117 |
131 | Spontaneous abortion (HP:0005268) | 1.57661102 |
132 | Malnutrition (HP:0004395) | 1.54839518 |
133 | Obstructive lung disease (HP:0006536) | 1.54247638 |
134 | Chronic obstructive pulmonary disease (HP:0006510) | 1.54247638 |
135 | Epistaxis (HP:0000421) | 1.53483475 |
136 | Abnormality of secondary sexual hair (HP:0009888) | 1.52860728 |
137 | Abnormality of the axillary hair (HP:0100134) | 1.52860728 |
138 | Abnormality of carpal bone ossification (HP:0006257) | 1.52838831 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TGFBR2 | 6.55135304 |
2 | IRAK3 | 2.89834632 |
3 | MAPK15 | 2.81298044 |
4 | CAMK1D | 2.63947273 |
5 | RIPK4 | 2.60234750 |
6 | GRK7 | 2.59783465 |
7 | DDR2 | 2.43191569 |
8 | TYK2 | 2.40475434 |
9 | CSF1R | 2.22211447 |
10 | CAMK1G | 2.21566311 |
11 | ACVR1B | 1.97995290 |
12 | ERN1 | 1.96428265 |
13 | TBK1 | 1.90953946 |
14 | MAP3K14 | 1.87898951 |
15 | ICK | 1.81084482 |
16 | NME2 | 1.69138429 |
17 | PDGFRA | 1.65815712 |
18 | JAK1 | 1.64731544 |
19 | SIK1 | 1.64607723 |
20 | MAPK12 | 1.62230590 |
21 | MAP3K13 | 1.56543949 |
22 | PRPF4B | 1.55174600 |
23 | PDK2 | 1.54148248 |
24 | BLK | 1.53168697 |
25 | CDC42BPA | 1.48239707 |
26 | IRAK4 | 1.47113509 |
27 | TYRO3 | 1.36710194 |
28 | TNIK | 1.33259545 |
29 | TRIB3 | 1.31704759 |
30 | PAK4 | 1.31071020 |
31 | EPHB1 | 1.27897483 |
32 | KIT | 1.20199556 |
33 | STK10 | 1.17636667 |
34 | TGFBR1 | 1.16931882 |
35 | MAPK7 | 1.15456079 |
36 | MST1R | 1.13710744 |
37 | CDK3 | 1.11692134 |
38 | IKBKB | 1.11606942 |
39 | MAP3K3 | 1.08901373 |
40 | MAP4K1 | 1.06811352 |
41 | JAK2 | 1.04477696 |
42 | NEK9 | 1.03933342 |
43 | CSK | 1.02376976 |
44 | ABL2 | 1.00636099 |
45 | IKBKE | 0.98801118 |
46 | HCK | 0.97684960 |
47 | PTK6 | 0.96566741 |
48 | MAP2K3 | 0.95952008 |
49 | FRK | 0.90955564 |
50 | ZAP70 | 0.89061322 |
51 | INSRR | 0.89034244 |
52 | SGK3 | 0.88413029 |
53 | CDK12 | 0.86650518 |
54 | PBK | 0.85766793 |
55 | TIE1 | 0.85347649 |
56 | FGFR3 | 0.84341657 |
57 | MARK2 | 0.83781960 |
58 | LATS2 | 0.83446715 |
59 | MAP3K1 | 0.83236148 |
60 | RET | 0.82166390 |
61 | PRKAA2 | 0.82013818 |
62 | FGR | 0.81633740 |
63 | PDGFRB | 0.81142736 |
64 | EPHA4 | 0.80456041 |
65 | TAOK3 | 0.79415356 |
66 | MATK | 0.79211258 |
67 | FES | 0.78162074 |
68 | MOS | 0.77734102 |
69 | SGK2 | 0.76918533 |
70 | JAK3 | 0.76329257 |
71 | MAP3K11 | 0.75974955 |
72 | LYN | 0.74554947 |
73 | WNK4 | 0.73920652 |
74 | SIK2 | 0.73333348 |
75 | FGFR4 | 0.72204578 |
76 | PDPK1 | 0.71935261 |
77 | MAP3K6 | 0.71478963 |
78 | ERBB4 | 0.70907005 |
79 | EPHB2 | 0.69335355 |
80 | RIPK1 | 0.69180087 |
81 | AKT3 | 0.68302230 |
82 | LMTK2 | 0.66716243 |
83 | TAOK2 | 0.64691030 |
84 | EGFR | 0.64441262 |
85 | ITK | 0.64290740 |
86 | MARK3 | 0.64143836 |
87 | CLK1 | 0.63541332 |
88 | DMPK | 0.62890503 |
89 | PDK1 | 0.62426113 |
90 | * IGF1R | 0.61173324 |
91 | TRPM7 | 0.61048723 |
92 | CAMK4 | 0.60670916 |
93 | LCK | 0.59915215 |
94 | FGFR2 | 0.59737833 |
95 | DAPK2 | 0.59503873 |
96 | MAP3K2 | 0.59392261 |
97 | RPS6KA2 | 0.58392349 |
98 | PAK2 | 0.57062199 |
99 | CAMKK2 | 0.56788352 |
100 | MAP3K5 | 0.56551827 |
101 | OXSR1 | 0.54478875 |
102 | CHUK | 0.54409399 |
103 | ARAF | 0.53902721 |
104 | BMX | 0.53193724 |
105 | PIK3CA | 0.53000028 |
106 | FER | 0.52456359 |
107 | TESK2 | 0.50477966 |
108 | SYK | 0.49658389 |
109 | LATS1 | 0.48689851 |
110 | TAOK1 | 0.48418988 |
111 | CDK6 | 0.48335392 |
112 | GSK3A | 0.47079693 |
113 | CAMKK1 | 0.43929827 |
114 | KSR2 | 0.42336285 |
115 | INSR | 0.42118816 |
116 | MAPK11 | 0.41922585 |
117 | PIK3CG | 0.41570621 |
118 | PRKG2 | 0.41077021 |
119 | PTK2B | 0.40737675 |
120 | NEK6 | 0.40534133 |
121 | RPS6KL1 | 0.40386755 |
122 | RPS6KC1 | 0.40386755 |
123 | MTOR | 0.39538042 |
124 | MAP3K10 | 0.39326062 |
125 | MAP2K2 | 0.38697108 |
126 | MAPK4 | 0.38671354 |
127 | EIF2AK2 | 0.38519233 |
128 | GRK1 | 0.38503591 |
129 | ABL1 | 0.38458231 |
130 | PKN2 | 0.38009445 |
131 | NUAK1 | 0.37398692 |
132 | IRAK2 | 0.37057111 |
133 | STK39 | 0.36687740 |
134 | PHKG2 | 0.36579777 |
135 | PHKG1 | 0.36579777 |
136 | MET | 0.35987157 |
137 | SRC | 0.35937025 |
138 | MAP3K9 | 0.35598043 |
139 | ERBB2 | 0.34174594 |
140 | PRKD1 | 0.33869552 |
141 | TNK2 | 0.31976887 |
142 | MELK | 0.31936223 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.79018876 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.66174702 |
3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.84251847 |
4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.47444585 |
5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.28710144 |
6 | Lysosome_Homo sapiens_hsa04142 | 2.21447570 |
7 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.88687415 |
8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.86524443 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.81788663 |
10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73619329 |
11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.60613156 |
12 | Pertussis_Homo sapiens_hsa05133 | 1.55054017 |
13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.48822230 |
14 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.42665970 |
15 | ABC transporters_Homo sapiens_hsa02010 | 1.41804603 |
16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.32006925 |
17 | Tuberculosis_Homo sapiens_hsa05152 | 1.29335458 |
18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28481903 |
19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28248828 |
20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.26795817 |
21 | Mineral absorption_Homo sapiens_hsa04978 | 1.22479790 |
22 | Prion diseases_Homo sapiens_hsa05020 | 1.21034845 |
23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.20552963 |
24 | Bile secretion_Homo sapiens_hsa04976 | 1.20284844 |
25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.19981985 |
26 | Malaria_Homo sapiens_hsa05144 | 1.19697929 |
27 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.16430418 |
28 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.14281200 |
29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07528714 |
30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06849633 |
31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04836312 |
32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.04819968 |
33 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.04717279 |
34 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01896154 |
35 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.00005424 |
36 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99146629 |
37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.96369469 |
38 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94126235 |
39 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93062636 |
40 | Galactose metabolism_Homo sapiens_hsa00052 | 0.91616639 |
41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91161993 |
42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90420755 |
43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89494979 |
44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89086711 |
45 | Influenza A_Homo sapiens_hsa05164 | 0.87492572 |
46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.86869424 |
47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86583077 |
48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85301000 |
49 | Asthma_Homo sapiens_hsa05310 | 0.81599692 |
50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81377452 |
51 | Legionellosis_Homo sapiens_hsa05134 | 0.80740629 |
52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80329468 |
53 | Amoebiasis_Homo sapiens_hsa05146 | 0.79892784 |
54 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79639802 |
55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78595187 |
56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73764377 |
57 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73100221 |
58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71886716 |
59 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.71434809 |
60 | Salmonella infection_Homo sapiens_hsa05132 | 0.70860929 |
61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70421613 |
62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68625753 |
63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67344958 |
64 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66507385 |
65 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65477376 |
66 | Phagosome_Homo sapiens_hsa04145 | 0.64604719 |
67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64210248 |
68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64199761 |
69 | Measles_Homo sapiens_hsa05162 | 0.62295690 |
70 | Lysine degradation_Homo sapiens_hsa00310 | 0.61468857 |
71 | Platelet activation_Homo sapiens_hsa04611 | 0.60835872 |
72 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60476724 |
73 | Bladder cancer_Homo sapiens_hsa05219 | 0.60289389 |
74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59543905 |
75 | Hepatitis C_Homo sapiens_hsa05160 | 0.59483264 |
76 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58768261 |
77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58703432 |
78 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.57983443 |
79 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.55879854 |
80 | Allograft rejection_Homo sapiens_hsa05330 | 0.55825531 |
81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55810191 |
82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55641090 |
83 | Peroxisome_Homo sapiens_hsa04146 | 0.55426332 |
84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53518499 |
85 | Adherens junction_Homo sapiens_hsa04520 | 0.50786725 |
86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50238532 |
87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49184585 |
88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49176375 |
89 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48945412 |
90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48884879 |
91 | Insulin resistance_Homo sapiens_hsa04931 | 0.48725868 |
92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.47778831 |
93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47195348 |
94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46877754 |
95 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45220771 |
96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45201339 |
97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44918508 |
98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44085366 |
99 | Focal adhesion_Homo sapiens_hsa04510 | 0.43734111 |
100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43606240 |
101 | Salivary secretion_Homo sapiens_hsa04970 | 0.42313265 |
102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41685260 |
103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40295494 |
104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39978613 |
105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39029218 |
106 | Apoptosis_Homo sapiens_hsa04210 | 0.38820183 |
107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38688479 |
108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38578410 |
109 | Endocytosis_Homo sapiens_hsa04144 | 0.38417688 |
110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38228710 |
111 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.38169722 |
112 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.38039534 |
113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.37168605 |
114 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36865237 |
115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36604448 |
116 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35671653 |
117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35291285 |
118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35121664 |
119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34789851 |
120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33695274 |
121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33619394 |
122 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33383890 |
123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33276731 |
124 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33106702 |
125 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.33046574 |
126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29714186 |
127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29020073 |
128 | Hepatitis B_Homo sapiens_hsa05161 | 0.26757873 |
129 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.22823693 |
130 | Viral myocarditis_Homo sapiens_hsa05416 | 0.21062770 |
131 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20893850 |
132 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20715773 |